Memsorb for Anesthesia Management
(memsorb Trial)
Trial Summary
What is the purpose of this trial?
The drawbacks of chemical CO2 absorbers include the production of compounds harmful to patients that also lead into increased cost and environmental impact, as well as the daily disposal of compound special waste. Sustainable management of general anesthesia is a growing concern. Continually diluting anesthetic circuits, and the disposal of chemical granulate are serious environmental problems.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug memsorb for anesthesia management?
The research suggests that adding dexmedetomidine to pain management can reduce the need for other pain medications like meperidine, which may imply that memsorb, if it includes similar components, could be effective in managing anesthesia by potentially reducing the amount of other drugs needed.12345
How is the drug memsorb different from other anesthesia management drugs?
Memsorb, also known as mesna, is unique because it acts as a protective agent against oxidative stress and tissue damage, which is not a common feature of typical anesthesia management drugs. It is known for its ability to neutralize harmful substances and protect tissues, which may offer additional benefits during anesthesia.678910
Research Team
Orlando Hung, MD
Principal Investigator
Nova Scotia Health Authority
Eligibility Criteria
This trial is for English-speaking patients with a low to medium risk status (Class I, II, III) according to the American Society of Anesthesiologists. It's not suitable for pregnant individuals, high-risk patients (Class IV), those needing emergency surgery, or people with elevated brain pressure or severe respiratory diseases like COPD and asthma.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard care using either the memsorb CO2 filter or a standard CO2 absorber during surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment, including measurements of various physiological parameters
Treatment Details
Interventions
- memsorb
Find a Clinic Near You
Who Is Running the Clinical Trial?
DMF Medical Incorporated
Lead Sponsor